[go: up one dir, main page]

DK1353910T3 - Lactamforbindelse - Google Patents

Lactamforbindelse

Info

Publication number
DK1353910T3
DK1353910T3 DK01996530T DK01996530T DK1353910T3 DK 1353910 T3 DK1353910 T3 DK 1353910T3 DK 01996530 T DK01996530 T DK 01996530T DK 01996530 T DK01996530 T DK 01996530T DK 1353910 T3 DK1353910 T3 DK 1353910T3
Authority
DK
Denmark
Prior art keywords
lactam
Prior art date
Application number
DK01996530T
Other languages
English (en)
Inventor
Thomas Mitchell Koenig
James Edmund Audia
David Mitchell
Stacey Leigh Mcdaniel
Lynne Ann Buccilli
Gary Lowell Engel
James Abraham Aikins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1353910T3 publication Critical patent/DK1353910T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK01996530T 2000-11-17 2001-11-02 Lactamforbindelse DK1353910T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24965600P 2000-11-17 2000-11-17
PCT/US2001/027795 WO2002040451A2 (en) 2000-11-17 2001-11-02 Lactam compound

Publications (1)

Publication Number Publication Date
DK1353910T3 true DK1353910T3 (da) 2007-09-10

Family

ID=22944436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996530T DK1353910T3 (da) 2000-11-17 2001-11-02 Lactamforbindelse

Country Status (33)

Country Link
US (1) US20040248878A1 (da)
EP (1) EP1353910B1 (da)
JP (1) JP4116431B2 (da)
KR (1) KR20030045194A (da)
CN (2) CN100516047C (da)
AR (1) AR031356A1 (da)
AT (1) ATE362919T1 (da)
AU (2) AU2432102A (da)
BR (1) BR0115424A (da)
CA (1) CA2425497C (da)
CY (1) CY1106682T1 (da)
CZ (1) CZ20031340A3 (da)
DE (1) DE60128587T2 (da)
DK (1) DK1353910T3 (da)
DZ (1) DZ3454A1 (da)
EA (1) EA006919B1 (da)
EC (1) ECSP034598A (da)
ES (1) ES2286162T3 (da)
HR (1) HRP20030385A2 (da)
HU (1) HUP0301862A3 (da)
IL (1) IL155275A0 (da)
MX (1) MXPA03004250A (da)
MY (1) MY141607A (da)
NO (1) NO325217B1 (da)
PE (1) PE20020798A1 (da)
PL (1) PL211018B1 (da)
PT (1) PT1353910E (da)
SK (1) SK287794B6 (da)
SV (1) SV2003000741A (da)
TW (1) TWI235151B (da)
UA (1) UA77165C2 (da)
WO (1) WO2002040451A2 (da)
ZA (1) ZA200303411B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74849C2 (en) * 2000-11-17 2006-02-15 Lilly Co Eli Lactam
PT1572215E (pt) 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
AU2004205642C1 (en) 2003-01-14 2012-01-12 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
ES2413705T3 (es) 2005-04-08 2013-07-17 Daiichi Sankyo Company, Limited Derivado de piridilmetilsulfona
US8258302B2 (en) 2006-01-31 2012-09-04 Api Corporation Method for producing benzazepinone
TW200920362A (en) 2007-09-11 2009-05-16 Daiichi Sankyo Co Ltd Alkylsulfone derivatives
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
SG188548A1 (en) 2010-09-22 2013-04-30 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
KR101899014B1 (ko) 2012-01-06 2018-09-17 삼성전자주식회사 비엘디씨 모터의 제어 장치 및 그 방법
CN102690231B (zh) * 2012-04-11 2014-07-09 南京友杰医药科技有限公司 治疗阿尔茨海默病潜在药物司马西特的合成方法
EP2987496B1 (en) 2013-04-19 2018-08-08 National University Corporation Okayama University Treatment agent for cognitive disorders, induced by amyloid -protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these
NZ734220A (en) 2015-01-06 2022-01-28 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. S1p1 수용체-관련 장애에서의 사용을 위한 (r)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[b]인돌-3-일)아세트산 (화합물 1)의 결정성 l-아르기닌 염
KR20190116416A (ko) 2017-02-16 2019-10-14 아레나 파마슈티칼스, 인크. 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1
US20230118517A1 (en) 2020-03-26 2023-04-20 Seagen Inc. Methods of treating multiple myeloma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0951466T1 (sl) * 1996-12-23 2009-10-31 Elan Pharm Inc Cikloalkili, laktami, laktoni in sorodne spojine, farmacevtske zmesi, ki jih vsebujejo, in metode inhibicije sproščanja beta-amiloidnega peptida in/ali njegove sinteze z uporabo takih spojin
EP1089977A1 (en) * 1998-06-22 2001-04-11 Elan Pharmaceuticals, Inc. Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
EP1230220A1 (en) * 1999-11-09 2002-08-14 Eli Lilly And Company Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis

Also Published As

Publication number Publication date
ATE362919T1 (de) 2007-06-15
SK287794B6 (sk) 2011-10-04
CN101624372A (zh) 2010-01-13
AU2002224321B2 (en) 2006-10-19
WO2002040451A3 (en) 2003-08-28
CZ20031340A3 (cs) 2004-06-16
MXPA03004250A (es) 2003-09-22
HRP20030385A2 (en) 2003-08-31
DE60128587T2 (de) 2008-01-31
IL155275A0 (en) 2003-11-23
WO2002040451A2 (en) 2002-05-23
CN1575282A (zh) 2005-02-02
JP4116431B2 (ja) 2008-07-09
NO20032215L (no) 2003-07-16
HUP0301862A2 (hu) 2003-09-29
BR0115424A (pt) 2003-10-21
JP2004521084A (ja) 2004-07-15
DE60128587D1 (de) 2007-07-05
MY141607A (en) 2010-05-31
AU2432102A (en) 2002-05-27
CA2425497C (en) 2010-08-17
CA2425497A1 (en) 2002-05-23
EA200300579A1 (ru) 2003-12-25
SK5432003A3 (en) 2004-09-08
TWI235151B (en) 2005-07-01
US20040248878A1 (en) 2004-12-09
PE20020798A1 (es) 2002-09-06
HUP0301862A3 (en) 2007-09-28
UA77165C2 (en) 2006-11-15
DZ3454A1 (fr) 2002-05-23
CY1106682T1 (el) 2012-05-23
EA006919B1 (ru) 2006-04-28
ECSP034598A (es) 2003-06-25
PL360991A1 (en) 2004-09-20
PT1353910E (pt) 2007-08-20
PL211018B1 (pl) 2012-03-30
ES2286162T3 (es) 2007-12-01
EP1353910A2 (en) 2003-10-22
NO325217B1 (no) 2008-02-25
EP1353910B1 (en) 2007-05-23
SV2003000741A (es) 2003-01-13
KR20030045194A (ko) 2003-06-09
CN100516047C (zh) 2009-07-22
ZA200303411B (en) 2004-08-02
NO20032215D0 (no) 2003-05-15
AR031356A1 (es) 2003-09-17

Similar Documents

Publication Publication Date Title
NO20032236L (no) Laktamforbindelse
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
ATE312098T1 (de) Thiazinoxazolidinon
DE50100710D1 (de) Wischblatt
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
DK1353910T3 (da) Lactamforbindelse
PT1268453E (pt) Metabolitos de agonista/antagonista de estrogenio
DE10192638T1 (de) Bohrstangenladevorrichtung
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
DE50011511D1 (de) Blowby-Heizung
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
PT1317179E (pt) Formulacoes de mesotriona
AR027931A1 (es) Antitranspirantes
ATE476423T1 (de) Benzoylpyridazine
DE10052925B4 (de) Schaukelbett
DE50007634D1 (de) Kardioplegieballonkatheter
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
DE10195909T1 (de) Viehfüttervorrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
ATE284887T1 (de) Thienopyrrolidinone